Review of Intranasal Fentanyl Use for Pain in Children Treated in Pediatric Surgical Emergencies at Strasbourg University Hospital

What this Trial Is About

Emergency trauma departments treat many patients each year who experience pain as their main symptom. In recent years, intranasal fentanyl has been introduced as a treatment option for pain in emergency settings. Previous studies have shown its effectiveness and safety for musculoskeletal pain. This research aims to review how well intranasal fentanyl is prescribed and monitored in the pediatric emergency department at Strasbourg University Hospital over recent years. This study involves a retrospective review of records for children under 18 treated with intranasal fentanyl at the pediatric emergency department between August 2022 and September 2024. Researchers will evaluate the appropriateness of fentanyl prescriptions, how the medication was administered, and the monitoring of patients during treatment. The study focuses on current medical practices without introducing new treatments. Participants will not be actively involved since this is a retrospective study. Researchers will analyze existing health data to assess the quality of care related to intranasal fentanyl use. The main outcome measures include evaluating the relevance of prescription, administration, and monitoring of the fentanyl protocol up to 2 years after treatment. The study is sponsored by the University Hospital in Strasbourg, and results will help improve future pain management in pediatric emergencies.

Evaluation of the "Intranasal Fentanyl" Protocol in Pediatric Surgical Emergencies at Strasbourg University Hospital